What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling
Introduction There is a critical need to understand the optimal treatment regimen in patients with potentially resectable stage III-N2 nonsmall cell lung cancer (NSCLC). Methods A systematic review of randomised controlled trials was carried out using a literature search including the CDSR, CENTRAL,...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
European Respiratory Society
2023-04-01
|
| Colección: | ERJ Open Research |
| Acceso en línea: | http://openres.ersjournals.com/content/9/2/00299-2022.full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|